about
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake.
P2860
Q34334262-60A32BBD-787D-4541-ABDE-7CF4E1398E36Q35085434-A9BB5E86-1CC4-488D-A501-965F2E18F6CDQ35101262-FB23B8E4-D10F-41EC-8753-1CD5D03FE702Q36711237-E4163885-EEBE-4856-858A-555D9BAEDD57Q37831911-E563D35F-C1B7-47BD-9A79-89D5AC7F9CB6Q44814545-2BD12D37-A848-4E80-8B41-40DC00D45978Q48655114-54536374-F9EF-45A0-AEBD-3353D1A3CE78
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Metformin increases plasma ghrelin in Type 2 diabetes.
@ast
Metformin increases plasma ghrelin in Type 2 diabetes.
@en
type
label
Metformin increases plasma ghrelin in Type 2 diabetes.
@ast
Metformin increases plasma ghrelin in Type 2 diabetes.
@en
prefLabel
Metformin increases plasma ghrelin in Type 2 diabetes.
@ast
Metformin increases plasma ghrelin in Type 2 diabetes.
@en
P2093
P2860
P1476
Metformin increases plasma ghrelin in Type 2 diabetes
@en
P2093
Chris J Pemberton
Evan J Begg
M Peter Moore
P2860
P304
P356
10.1111/J.1365-2125.2009.03372.X
P407
P577
2009-12-01T00:00:00Z